Vera Therapeutics kept at Overweight; JP Morgan lifts PT
JP Morgan maintained Vera Therapeutics at Overweight and raised its price target to $83.00 per share from $76.00, according to TradingView News ratings actions.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.